HIGHLIGHTS
- What: The aim of this study was to investigate the efficacy and safety of topical lifitegrast in the management of oGVHD.
- Who: Calvin W. Wong and colleagues from the Ophthalmology, McGovern Medical School, University of Texas Health Science Center at, USA , have published the paper: Review began 07/16/2024 Review ended 08/02/2024 Published 08/08/2024 © Copyright, in the Journal: (JOURNAL) of August/08,/2024
SUMMARY
Graft-versus-host disease (GVHD) is a common sequela of hematopoietic stem_cell transplant (HSCT). Ocular involvement is one manifestation of chronic GVHD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.